Kunos L, Kováts Z, Muraközy G, Süttö Z, Bohács A, Czebe K, Lang G, Rényi-Vámos F, Klepetko W, Müller V
Department of Pulmonology, Semmelweis University, Budapest, Hungary.
Transplant Proc. 2011 May;43(4):1292-3. doi: 10.1016/j.transproceed.2011.03.089.
Lung transplantation is the only treatment for end-stage lung disease in selected patients. After lung transplantation, patient recovery is often slow owing to severe underlying diseases in the patient producing hypoxemia before, during, and after surgery, as well as infections and rejection episodes. Postoperative breathing and ventillatory disorders are also associated with diaphragmatic dysfunction and/or phrenic nerve damage.
Herein we have reported a case of a 35-year-old man undergoing bilateral lung transplantation owing to worsening of chronic respiratory failure from cystic fibrosis. After uncomplicated surgery, weaning was delayed due to nighttime dyspnea and hypoxemia attributed to diaphragm dysfunction. After improvement of diaphragm function, the symptoms persisted, requiring noninvasive nocturnal ventilatory support. Polysomnography confirmed severe mixed sleep apnea.
Effective treatment with noninvasive bi-level positive airway pressure spontaneous/timed mode (BiPAP S/T) ventilation during the nights rendered the patient symptom free. Polysomnography confirmed successful treatment.
Disordered breathing while sleeping is common after solid organ transplantation. BiPAP S/T ventilator therapy was effective to the treat dominantly central sleep apnea in our patient.
肺移植是特定患者终末期肺病的唯一治疗方法。肺移植后,由于患者存在严重基础疾病,在手术前、手术期间及手术后均会导致低氧血症,以及感染和排斥反应,患者恢复通常较慢。术后呼吸和通气障碍也与膈肌功能障碍和/或膈神经损伤有关。
在此,我们报告了一例35岁男性因囊性纤维化导致慢性呼吸衰竭加重而接受双侧肺移植的病例。手术顺利,但由于夜间呼吸困难和低氧血症(归因于膈肌功能障碍),脱机延迟。膈肌功能改善后,症状仍持续存在,需要夜间无创通气支持。多导睡眠图证实存在严重的混合性睡眠呼吸暂停。
夜间采用无创双水平气道正压通气自发/定时模式(BiPAP S/T)进行有效治疗后,患者症状消失。多导睡眠图证实治疗成功。
实体器官移植后睡眠呼吸紊乱很常见。BiPAP S/T通气治疗对我们患者的主要中枢性睡眠呼吸暂停有效。